Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul-Aug;13(4):100095.
doi: 10.1016/j.apjo.2024.100095. Epub 2024 Aug 28.

Development of oculomics artificial intelligence for cardiovascular risk factors: A case study in fundus oculomics for HbA1c assessment and clinically relevant considerations for clinicians

Affiliations

Development of oculomics artificial intelligence for cardiovascular risk factors: A case study in fundus oculomics for HbA1c assessment and clinically relevant considerations for clinicians

Joshua Ong et al. Asia Pac J Ophthalmol (Phila). 2024 Jul-Aug.

Abstract

Artificial Intelligence (AI) is transforming healthcare, notably in ophthalmology, where its ability to interpret images and data can significantly enhance disease diagnosis and patient care. Recent developments in oculomics, the integration of ophthalmic features to develop biomarkers for systemic diseases, have demonstrated the potential for providing rapid, non-invasive methods of screening leading to enhance in early detection and improve healthcare quality, particularly in underserved areas. However, the widespread adoption of such AI-based technologies faces challenges primarily related to the trustworthiness of the system. We demonstrate the potential and considerations needed to develop trustworthy AI in oculomics through a pilot study for HbA1c assessment using an AI-based approach. We then discuss various challenges, considerations, and solutions that have been developed for powerful AI technologies in the past in healthcare and subsequently apply these considerations to the oculomics pilot study. Building upon the observations in the study we highlight the challenges and opportunities for advancing trustworthy AI in oculomics. Ultimately, oculomics presents as a powerful and emerging technology in ophthalmology and understanding how to optimize transparency prior to clinical adoption is of utmost importance.

Keywords: Artificial intelligence; Machine learning; Oculomics; Ophthalmology; Reliability; Trustworthy.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Male to female ratio of patients in cohort for pilot study.
Fig. 2.
Fig. 2.
HbA1c level distributions for male and female patients.
Fig. 3.
Fig. 3.
Age distribution of patients in pilot study cohort.
Fig. 4.
Fig. 4.
Mean and standard deviation of HbA1c level by age group.
Fig. 5.
Fig. 5.
Confusion matrix for output of VGG 19 model.
Fig. 6.
Fig. 6.
Three-stage diabetes triage process architecture based on Ensemble Model.
Fig. 7.
Fig. 7.
Ensemble model ROC curve.
Fig. 8.
Fig. 8.
Ensemble model confusion matrix.
Fig. 9.
Fig. 9.
Confusion matrix of predictions when model is trained on senior and youth groups, respectively.
Fig. 10.
Fig. 10.
Confusion matrix of model predictions of sex based on fundus images.
Fig. 11.
Fig. 11.
Sample of results comparing Grad-CAM output for classifying male vs female.
Fig. 12.
Fig. 12.
Comparison of Grad-CAM output on different classes.

Similar articles

References

    1. Al Kuwaiti A, Nazer K, Al-Reedy A, et al. A review of the role of artificial intelligence in healthcare. J Pers Med. 2023;13(6):951. 10.3390/jpm13060951. - DOI - PMC - PubMed
    1. Khanna NN, Maindarkar MA, Viswanathan V, et al. Economics of artificial intelligence in healthcare: diagnosis vs. treatment. Healthcare. 2022;10(12):2493. 10.3390/healthcare10122493. - DOI - PMC - PubMed
    1. Yan Q, Weeks DE, Xin H, et al. Deep-learning-based prediction of late age-related macular degeneration progression. Nat Mach Intell. 2020;2(2):141–150. 10.1038/s42256-020-0154-9. - DOI - PMC - PubMed
    1. Naji Y, Mahdaoui M, Klevor R, Kissani N. Artificial intelligence and multiple sclerosis: up-to-date review. Cureus; 15(9): e45412. DOI: 10.7759/cureus.45412. - DOI - PMC - PubMed
    1. Gensure RH, Chiang MF, Campbell JP. Artificial intelligence for retinopathy of prematurity. Curr Opin Ophthalmol. 2020;31(5):312–317. doi: 10.1097/ICU.0000000000000680. - DOI - PMC - PubMed